Stoke Therapeutics Market Sentiment

Stoke Therapeutics Inc

STOKNASDAQ

Trade with Public

$26.42

0.742.88%

Últ. Act.: Oct 22, 10:12 AM

$25.90

0.220.86%

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Ganancias: Beneficios de Q3 2026 dentro de 7 días de ahora en jue oct 29th, después del cierre del mercado

Stoke Therapeutics Market Sentiment - Benzinga

Stoke Therapeutics Market Sentiment

Market sentiment signals for Stoke Therapeutics (STOK): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 19.2% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

15 analysts

Options Flow (P/C)

—

0 calls · 1 puts

Avg Consensus PT

$41

+55.8%

Highest Price Target

$60

+127.1%

Guggenheim

Lowest Price Target

$24

-9.2%

Chardan Capital

Short Interest

19.2%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 21, 2026	JP Morgan	Jessica Fye—	+51.4%	$40	Reinstates	Overweight
Aug 4, 2026	Guggenheim	Yatin Suneja—	+127.1%	$60 → $60	Maintained	Buy
Aug 4, 2026	Wedbush	Laura Chico—	+51.4%	$38 → $40	Maintained	Outperform
Aug 4, 2026	Canaccord Genuity	Sumant Kulkarni—	+119.5%	$60 → $58	Maintained	Buy
Aug 4, 2026	Chardan Capital	Keay Nakae—	+32.5%	$35 → $35	Maintained	Buy
Jul 13, 2026	Goldman Sachs	Kevin Strang—	+66.5%	$44	Initiate	Buy
May 11, 2026	BTIG	Thomas Shrader—	+47.6%	$39 → $39	Maintained	Buy
Mar 20, 2026	Canaccord Genuity	Sumant Kulkarni—	+127.1%	$36 → $60	Maintained	Buy
Mar 19, 2026	BTIG	Thomas Shrader—	+47.6%	$39 → $39	Maintained	Buy
Mar 18, 2026	Wedbush	Laura Chico—	+43.8%	$36 → $38	Maintained	Outperform
Mar 18, 2026	Chardan Capital	Keay Nakae—	+32.5%	$35 → $35	Maintained	Buy
Mar 17, 2026	Wedbush	Laura Chico—	+43.8%	$36 → $38	Maintained	Outperform
Mar 17, 2026	Needham	Joseph Stringer—	+51.4%	$35 → $40	Maintained	Buy
Feb 24, 2026	Wolfe Research	Rudy Li—	+51.4%	$40	Initiate	Outperform
Jan 12, 2026	Wedbush	Laura Chico—	+36.3%	$32 → $36	Maintained	Outperform
Jan 5, 2026	Chardan Capital	Keay Nakae—	+32.5%	$24 → $35	Maintained	Buy
Jan 5, 2026	Canaccord Genuity	Sumant Kulkarni—	+36.3%	$28 → $36	Maintained	Buy
Dec 15, 2025	HC Wainwright & Co.	Ananda Ghosh—	+89.3%	$35 → $50	Maintained	Buy
Nov 5, 2025	Canaccord Genuity	Sumant Kulkarni—	+6.0%	$24 → $28	Maintained	Buy
Nov 5, 2025	Wedbush	Laura Chico—	+21.1%	$22 → $32	Maintained	Outperform
Nov 5, 2025	BTIG	Thomas Shrader—	+47.6%	$39 → $39	Maintained	Buy
Nov 3, 2025	JP Morgan	Jessica Fye—	-5.4%	$15 → $25	Maintained	Neutral
Oct 13, 2025	BTIG	Thomas Shrader—	+47.6%	$28 → $39	Maintained	Buy
Oct 10, 2025	Needham	Joseph Stringer—	+32.5%	$22 → $35	Maintained	Buy
Aug 13, 2025	Chardan Capital	Rudy Li—	-9.2%	$24 → $24	Maintained	Buy